High Point Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

High Point Bank & Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.11M	Buy	19,077 +150	+0.8%	+$8.2K	0.35%	56
2016 Q3	$1.02M	Hold	18,927	–	–	0.27%	59
2016 Q2	$1.39M	Hold	18,927	–	–	0.38%	46
2016 Q1	$1.21M	Sell	18,927 -250	-1%	-$15.8K	0.31%	53
2015 Q4	$1.32M	Hold	19,177	–	–	0.34%	49
2015 Q3	$1.14M	Sell	19,177 -200	-1%	-$12.7K	0.32%	55
2015 Q2	$1.29M	Sell	19,377 -853	-4%	-$56.2K	0.38%	53
2015 Q1	$1.3M	Sell	20,230 -175	-0.9%	-$11K	0.38%	58
2014 Q4	$1.21M	Sell	20,405 -393	-2%	-$22.2K	0.41%	59
2014 Q3	$1.06M	Sell	20,798 -1,000	-5%	-$50K	0.35%	62
2014 Q2	$1.06M	Buy	21,798 +1,100	+5%	+$54.2K	0.35%	61
2014 Q1	$1.07M	Sell	20,698 -350	-2%	-$18.6K	0.35%	62
2013 Q4	$1.12M	Buy	21,048 +100	+0.5%	+$5.09K	0.37%	59
2013 Q3	$969K	Sell	20,948 -75	-0.4%	-$3.29K	0.34%	63
2013 Q2	$940K	Buy	+21,023	New	+$913K	0.32%	63

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

High Point Bank & Trust's BMY Position: Q4 2016 in Review

High Point Bank & Trust increased its Bristol-Myers Squibb (BMY) stake by 0.79% in Q4 2016, buying an estimated $8.2K and bringing the position to 19,077 shares worth $1.11M. The position accounts for 0.35% of the portfolio, ranked #56.

High Point Bank & Trust first reported a position in BMY in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.39M in Q2 2016. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

High Point Bank & Trust held 19,077 shares of Bristol-Myers Squibb worth $1.11M as of Q4 2016.
High Point Bank & Trust bought 150 Bristol-Myers Squibb shares in Q4 2016, an estimated $8.2K.
Bristol-Myers Squibb made up 0.35% of High Point Bank & Trust's portfolio in Q4 2016, its #56 holding.
High Point Bank & Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 15 quarters since.
High Point Bank & Trust's Bristol-Myers Squibb position peaked at $1.39M in Q2 2016.
1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on High Point Bank & Trust's 13F filing for Q4 2016, filed 28 Feb 2017.